cyclovirobuxine D, 860-79-7

Articles:

PubMed:	Cyclovirobuxine D Induces Autophagy-Associated Cell Death via the Akt/mTOR Pathway in MCF-7 Human Breast Cancer Cells.
PubMed:	Experimental and theoretical investigation on the interaction between cyclovirobuxine D and human serum albumin.
PubMed:	Influence of cyclovirobuxine D on intracellular [Ca(2+)] regulation and the expression of the calcium cycling proteins in rat myocytes.
PubMed:	[Effects of CVB-D on hemodynamic in anaesthetized dogs in vivo].
PubMed:	Beneficial effect of Cyclovirobuxine D on heart failure rats following myocardial infarction.
PubMed:	Cyclovirobuxine D inhibits the currents of HERG potassium channels stably expressed in HEK293 cells.
PubMed:	[Studies of in vitro releasing properties on cyclovirobuxine D matrix-type patch].
PubMed:	Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis.
PubMed:	Short and efficient approach towards buxozine-C, an alkaloid from Buxus sempervirens.
PubMed:	[Determination of cyclovirobuxine-D in huangyangning tablets by RP-HPLC with gradient elution].
PubMed:	Sensitive HPLC-APCI-MS method for the determination of cyclovirobuxine D in human plasma.
PubMed:	High performance liquid chromatography - tandem mass spectrometric determination of cyclovirobuxine D in human plasma.
PubMed:	[Structural modification of cyclovirobuxine D and their inhibition activity on lipid peroxidation].
PubMed:	[Prodrug structural modifications of cyclovirobuxine D and their biological activity].
PubMed:	Regulation of Ca2+ movements by cyclovirobuxine D in ECV304 endothelial cells.
PubMed:	[Electrophysiologic study of the biphasic effects of cyclovirobuxine D on arrhythmias].
PubMed:	[Effects of cyclovirobuxine D on intracellular Ca2+ and L-type Ca2+ current in rat ventricular cardiomyocytes].
PubMed:	[Structural modification and bioactivity of cyclovirobuxine D].
PubMed:	[Determination of cyclovirobuxine D by RP-HPLC with precolumn fluorescence derivatization].
PubMed:	Coronary effects of cyclovirobuxine D in anesthetized pigs and in isolated porcine coronary arteries.
PubMed:	Hemodynamic effects of the intravenous administration of cyclovirobuxine D [correction of cyclorirobuxine D] in anesthetized pigs.
PubMed:	[Anti-atrial fibrillation effects of cyclovirobuxine-D and its electrophysiological mechanism studied on guinea pig atria].
PubMed:	Protective effect of cycloprotobuxine-A against cardiac arrhythmias induced by ouabain.
PubMed:	[Congestive heart failure treated by a combination of cyclovirobuxine D with digoxin].
PubMed:	Anti-arrhythmic action of cycloprotobuxine-A.
PubMed:	The beneficial effects of cyclovirobuxine D (CVBD) in coronary heart disease. A double blind analysis of 110 cases.
PubMed:	[Double blind study of the therapeutic effect of cyclovirobuxine D No. 1 on the left ventricular function in coronary heart disease].
PubMed:	[Clinical observation of 546 cases of coronary heart disease treated with cyclovirobuxine D].
PubMed:	[Some cardiovascular effects of cyclovirobuxine-D (author's transl)].
PubMed:	[Experimental analysis of the anti-arrhythmic and arrhythmia-inducing actions of cyclovirobuxine D (author's transl)].